We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · May 01, 2021

Systemic Corticosteroids for Cutaneous Immune-Related Adverse Events Do Not Impact Survival Outcomes in Advanced Cancer Patients

JAMA Dermatology


Additional Info

JAMA Dermatology
Association Between Systemic Corticosteroid Treatment for Cutaneous Immune-Related Adverse Events and Survival Outcomes in Patients With Advanced Cancer
JAMA Dermatol 2021 Apr 14;[EPub Ahead of Print], LL Thompson, J Yoon, NA Krasnow, MS Chang, EB Li, DE McMahon, ST Chen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading